Stock DOCS DOXIMITY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Doximity, Inc.

Equities

DOCS

US26622P1075

Market Closed - Nyse
Other stock markets
 16:00:02 2024-05-03 EDT 		5-day change 1st Jan Change
24.09 USD -0.95% Intraday chart for Doximity, Inc. +1.13% -14.09%
04-26 North American Morning Briefing : Tech Still in -2- DJ
04-25 JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target is $25 MT

Evolution of the average Target Price on Doximity, Inc.

Price target over the last 5 years

History of analyst recommendation changes

6394408e8fc3b9046.EMNBGSokDD-VIT8Httjzh1TmnfPCgyiz8eIcWvN7BK0.f4wzLRwdVWDial1K_LW3wB6XyZv060LHoZp2Y7EzUpx2izlPR0J8eqcTeg~b122cca3f2545ee953d22fe5ed516820

Analyst Recommendations on Doximity, Inc.

JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target is $25 MT
JPMorgan Adjusts Price Target on Doximity to $25 From $22, Maintains Underweight Rating MT
Leerink Partners Initiates Doximity at Market Perform Rating With $32 Price Target MT
Jefferies Raises Doximity's Price Target to $35 From $30, Buy Rating Kept MT
Wells Fargo Adjusts Price Target on Doximity to $27 From $25, Maintains Equalweight Rating MT
BofA Securities Upgrades Doximity to Neutral From Underperform, Adjusts Price Target to $29 From $21 MT
Morgan Stanley Raises Price Target on Doximity to $25 From $21, Cites 'Solid Quarter,' Keeps Underweight Rating MT
North American Morning Briefing : Investors Weigh Higher-For-Longer Rates DJ
Wells Fargo Adjusts Doximity Price Target to $25 From $37, Maintains Equal Weight Rating MT
Truist Securities Adjusts Price Target on Doximity to $28 From $33, Maintains Hold Rating MT
Needham Downgrades Doximity to Hold From Buy MT
Raymond James Adjusts Price Target on Doximity to $30 From $40, Keeps Outperform Rating MT
Guggenheim Downgrades Doximity to Neutral From Buy MT
Morgan Stanley Cuts Price Target on Doximity to $21 From $28, Notes Guidance 'Materially Below the Street,' Keeps Underperform Rating MT
Piper Sandler Downgrades Doximity to Neutral From Overweight, Adjusts Price Target to $36 From $38 MT
Truist Securities Adjusts Price Target on Doximity to $33 From $36, Keeps Hold Rating MT
Canaccord Genuity Adjusts Price Target on Doximity to $40 From $41, Maintains Buy Rating MT
Evercore ISI Group Adjusts Price Target on Doximity to $32 From $33, Maintains In Line Rating MT
Morgan Stanley Adjusts Price Target on Doximity to $28 From $29, Maintains Underweight Rating MT
Wells Fargo Downgrades Doximity to Equal Weight From Overweight, Adjusts Price Target to $37 From $39 MT
JPMorgan Adjusts Price Target on Doximity to $30 From $60, Maintains Underweight Rating MT
Wells Fargo Adjusts Doximity's Price Target to $39 From $44, Keeps Overweight Rating MT
Canaccord Genuity Adjusts Price Target on Doximity to $41 From $42, Maintains Buy Rating MT
Morgan Stanley Downgrades Doximity to Underweight From Equalweight, Adjusts Price Target to $29 From $32 MT
Wells Fargo Adjusts Price Target on Doximity to $44 From $38, Maintains Overweight Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
24.09 USD
Average target price
29.77 USD
Spread / Average Target
+23.58%
High Price Target
35 USD
Spread / Highest target
+45.29%
Low Price Target
25 USD
Spread / Lowest Target
+3.78%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Doximity, Inc.

JPMorgan Chase
Leerink Partners
Jefferies & Co.
Wells Fargo Securities
BofA Securities
Morgan Stanley
Truist Securities
Needham & Co.
Raymond James
Guggenheim
Piper Sandler
Canaccord Genuity
Evercore ISI
BTIG
Berenberg Bank
KeyBanc Capital Markets
Goldman Sachs
SVB Securities LLC
Baird
SVB Leerink
William Blair & Co.

Ratings for Doximity, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. DOCS Stock
  4. Consensus Doximity, Inc.